Jurors awarded plaintiff John McDarby $13.5 million worth of punitive and compensatory damages in his lawsuit against Vioxx manufacturer Merck.
The jurors concluded that the drug maker delayed notifying patients of the risks once they were aware of the drug's danger.
Going Toward Medical Care
McDarby's wife Irma said that the money, which they will not get immediately because of appeals, will go toward giving her husband the constant medical care he needs. Merck plans to appeal based on their claim that the judge inappropriately restricted testimony and evidence.
First Trial Looking at Long-Term Use
The trial was the first to involve patients who used the drug for more than 18 months. This makes it an important case, as the study that prompted Merck to withdraw the drug from the market in 2004 found that its risks doubled after 18 months' use. The ruling could also lead to a criminal probe of Merck.
Merck faces almost 10,000 Vioxx-related lawsuits in state and federal courts. So far, the company has won two cases and lost two.